AVALANCHE BIOTECHNOLOGIES IN - COM (AAVL)

CUSIP: 05337G107

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
13,515,695
Share change
+914,948
Total reported value
$726,529,306
Price per share
$54.00
Number of holders
83
Value change
+$51,749,034
Number of buys
59
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 05337G107?
CUSIP 05337G107 identifies AAVL - AVALANCHE BIOTECHNOLOGIES IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVALANCHE BIOTECHNOLOGIES IN - COM (AAVL) as of Q4 2014

As of 31 Dec 2014, AVALANCHE BIOTECHNOLOGIES IN - COM (AAVL) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,515,695 shares. The largest 10 holders included FMR LLC, DEERFIELD MANAGEMENT CO, VHCP Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, Redmile Group, LLC, ADAGE CAPITAL PARTNERS GP LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, BlackRock Fund Advisors, and Tourbillon Capital Partners LP. This page lists 83 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.